Liability Risk and Insurance
Distilbene: development risk defence in France
Marketed in the late 1960s as a treatment for possible miscarriage, UCB Pharma’s “Distilbene” was subsequently found likely
to cause abnormalities or cancer in the child exposed
in utero
.